The pathology roadmap in Parkinson disease

Prion. Jan-Feb 2013;7(1):85-91. doi: 10.4161/pri.23582. Epub 2013 Jan 1.

Abstract

An under-appreciated clue about pathogenesis in Parkinson disease (PD) is the distribution of pathology in the early and middle stages of the disease. This pathological 'roadmap' shows that in addition to dopaminergic neurons in the substantia nigra pars compacta (SNc), a significant number of other central and peripheral neuronal populations exhibit Lewy pathology, phenotypic dysregulation or frank degeneration in PD patients. This spatially distributed, at-risk population of neurons shares a number of features, including autonomously generated activity, broad action potentials, low intrinsic calcium buffering capacity and long, poorly myelinated, highly branched axons. Many, and perhaps all, of these traits add to the metabolic burden in these neurons, suggesting that mitochondrial deficits could drive pathogenesis in PD-in agreement with a large segment of the literature. What is less clear is how this neuronal phenotype might shape the susceptibility to proteostatic dysfunction or to the spread of α-synuclein fibrils deposited in the extracellular space. The review explores the literature on these issues and their translational implications.

Keywords: Parkinson's disease; calcium; ion channel; mitochondria; neuroprotection; oxidant stress.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain / metabolism
  • Brain / pathology*
  • Calcium / metabolism
  • Humans
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Neurons / metabolism
  • Neurons / pathology
  • Oxidative Stress
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology*
  • Parkinson Disease / therapy
  • Substantia Nigra / metabolism
  • Substantia Nigra / pathology
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein
  • Calcium